audalis 60 mg
medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 60 mg
audalis 10 mg
medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 10 mg
audalis 18 mg
medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 18 mg
audalis 25 mg
medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 25 mg
audalis 40 mg
medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 40 mg
audalis 80 mg
medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 80 mg
audalis 100 mg
medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 100 mg
polivy
roche registration gmbh - polatuzumab vedotin - lymfom, b-celle - antineoplastiske midler - polivy i kombinasjon med bendamustine og rituximab er indisert for behandling av voksne pasienter med tilbakefall/ildfast diffuse store b-celle lymfom (dlbcl) som ikke er kandidater for haematopoietic stamcelletransplantasjon. polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (r-chp) is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma (dlbcl).
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - immune sera og immunglobuliner, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. se avsnitt 4. 4 og 5.
allopurinol aristo 300 mg
aristo pharma gmbh - allopurinol - tablett - 300 mg